$36.50
0.070.19%
Last update: Nov 12, 8:26 AM
Progyny Inc
PGNYNASDAQ
Progyny (PGNY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $0.52 | $0.46 | 13.0 % |
| Q2 | Aug 6, 2026 | $0.55 | $0.47 | 17.0 % |
| Q1 | May 7, 2026 | $0.50 | $0.39 | 28.2 % |
| Q4 | Feb 26, 2026 | $0.48 | $0.29 | 65.5 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $341.25M | $340.55M | 0.21 % |
| Q2 | Aug 6, 2026 | $350.51M | $348.77M | 0.50 % |
| Q1 | May 7, 2026 | $328.50M | $326.72M | 0.55 % |
| Q4 | Feb 26, 2026 | $318.40M | $310.13M | 2.67 % |
Progyny (PGNY) last issued guidance on November 4, 2026 for Q4 2026. The company guided earnings per share in the range of $0.53 - $0.58, compared to a consensus EPS estimate of $0.48. Progyny also guided revenue in the range of $344.7M - $364.7M for the period.
Compared to prior guidance, Progyny lowered its revenue forecast from a prior range of $1.36B - $1.39B.
Progyny has issued 36 guidance updates between November 28, 2022 and November 4, 2026. During this period, the company raised its outlook 17 times and lowered it 16 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.46 | $0.47 | $0.39 | $0.29 |
| Actual | $0.52 | $0.55 | $0.50 | $0.48 |
| Surprise | +13.0% | +17.0% | +28.2% | +65.5% |
| Revenue | ||||
| Estimate | $340.6M | $348.8M | $326.7M | $310.1M |
| Actual | $341.3M | $350.5M | $328.5M | $318.4M |
| Surprise | +0.21% | +0.50% | +0.55% | +2.67% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.49 | $0.57 |
| Revenue | ||
| Consensus | $355.9M | $364.7M |
